Teva wins US okay to buy Cephalon with conditions
October 07, 2011 at 17:04 PM EDT
WASHINGTON, Oct 7 (Reuters) - Teva Pharmaceutical Industries has won U.S. antitrust approval to buy the drugmaker Cephalon subject to several conditions, the Federal Trade Commission said on Friday.
